Qtrex Quantum

QTEX · NASDAQ

$1.39−$0.01 (−0.71%)TodayMarket closed ·
Prev close $1.40

About QTEX

QTREX Quantum Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company is headquartered in Ra'Anana, Central(Hamerkaz) and currently employs 37 full-time employees. The company went IPO on 2021-07-13. The firm is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The firm focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

Employees
37
Headquarters
Ra'anana, Central(HaMerkaz)
Listed
Jul 13, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies

QTEX key statistics

Market cap
93.23M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
23.62M
Volume
2.60M
Open price
$1.38
High today
$1.40
Low today
$1.36
52 Week high
$3.85
52 Week low
$0.283

Qtrex Quantum (QTEX) at a glance

As of Oct 23, 2026, Qtrex Quantum (QTEX) shares are priced at $1.39, giving the company a market cap of 93.23M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.36 and $1.40. The current price is 2.2% above the day's low and 0.7% below its high.

Volume so far is 2.60M shares, below the average of 23.62M shares a day.

Over the past year Qtrex Quantum has ranged from $0.283 to $3.85, and now sits 31% of the way up that range.

Qtrex Quantum met or beat analyst EPS estimates in 5 of the last 6 quarters. In Q2 FY26 it reported -$0.14 per share against an estimate of -$0.0306.

QTEX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 6 quarters, by 40.5% on average.

  1. Q4 FY22: reported -$0.034 per share against an estimate of -$0.3672
  2. Q1 FY23: reported -$0.281 per share against an estimate of -$0.357
  3. Q2 FY23: reported -$0.262 per share against an estimate of -$0.3264
  4. Q3 FY23: reported -$0.22 per share against an estimate of -$0.306
  5. Q4 FY23: reported -$0.17 per share against an estimate of -$0.2958
  6. Q2 FY26: reported -$0.14 per share against an estimate of -$0.0306

QTEX news

  • Mohd Haider

    QTREX Quantum Stock Is Trending: Here's Why It Rocketed 28% After-Hours

  • Press releaseGlobe Newswire

    Commercial Orders, FDA Firepower and Crypto Momentum

  • Henry Khederian

    QTREX Quantum Stock Climbs Friday: What's Going On?

  • Lekha Gupta

    What's Going On With QTREX Quantum Shares On Tuesday?

  • Lekha Gupta

    What's Going On With QTEX Quantum Stock On Tuesday?

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Kaustubh Bagalkote

    Why Is QTREX Quantum Stock Soaring On Tuesday?

  • 12 Health Care Stocks Moving In Friday's After-Market Session

Similar companies

Companies in the same industry as Qtrex Quantum

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.